Invesaro

Stocks FN Financial statements

Financial statements

Fabrinet financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Fabrinet files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue1,4201,3721,5841,6421,8792,2622,6452,8833,4194,641
Cost of revenue1,2491,2191,4051,4561,6581,9842,3092,5273,0064,085
Gross profit171153179186221279336356413557
Selling, general and administrative65.657.855.168.470.673.977.778.587.593.5
Operating income10693.8123117151205252278324463
Interest expense3.323.615.383.041.10.431.470.1200.08
Other non-operating income0.510.470.871.09-3.46-1.63-0.160.29-0.1857
Pre-tax income10488126119150207260311355555
Income tax6.743.865.285.762.146.5912.215.222.782.1
Net income97.184.2121113148200248296333473
EBITDA130123153148187243296327378531
EPS, basic2.632.263.293.074.025.436.798.179.2313.21
EPS, diluted2.572.213.233.013.955.366.738.109.1713.05
Shares, basic (weighted)36.937.336.836.936.936.936.536.23635.8
Shares, diluted (weighted)37.93837.437.737.637.436.936.636.336.3

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents134158181225303198231410306347
Short-term investments151174256263245280319449628528
Receivables2642472612733374535325927591,018
Inventory2392582943104225575204635811,021
Other current assets4.165.951114.522.625.442.987.8116196
Total current assets7998541,0241,1351,3531,5251,6532,0132,4293,160
Property, plant and equipment217220211228241292310307381615
Lease right-of-use assets8.076.74.081.635.345.773.97
Goodwill3.813.833.71
Intangible assets5.844.883.894.314.373.512.392.322.162.46
Other non-current assets1.580.080.120.21.830.650.640.490.6220.7
Total assets1,0331,0881,2551,3821,6161,8361,9802,3392,8313,911
Accounts payable2152202582523474403814426371,006
Accrued liabilities9.239.0198.9817.124.820.419.930.656.5
Deferred revenue2.241.561.681.983.047.8514.54.24
Short-term debt48.43.253.2512.212.212.212.20
Total current liabilities3112703133344445384825588101,403
Long-term debt57.739.527.415.20
Lease liabilities5.873.851.480.073.643.682.82
Other non-current liabilities2.723.062.715.663.442.412.082.213.2817.8
Total liabilities3523473924085045825115938501,457
Total debt48.43.2560.951.739.527.412.20
Paid-in capital133152158176189197207222238252
Retained earnings5486327558681,0161,2171,4651,7612,0932,566
Treasury stock0-42.4-47.8-68.5-87.3-147-195-234-360-365
Other comprehensive income-0.35-1.26-2.39-1.15-6.27-12.8-8.12-3.1410.30.97
Shareholders' equity6827418639741,1131,2541,4691,7461,9822,454
Total equity6827418639741,1131,2541,4691,7461,9822,454
Total liabilities and equity1,0331,0881,2551,3821,6161,8361,9802,3392,8313,911
Shares outstanding37.336.436.836.736.836.436.236.135.735.8

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income97.184.2121113148200248296333473
Depreciation and amortization23.829.129.930.936.338.743.84953.468.4
Stock-based compensation26.522.617.222.225.52828.128.43334.6
Deferred income tax0.76-1.60.89-0.51-4.21-0.16-2.863.18-5.16-2.14
Change in receivables-64.117.9-13.5-12.3-62.3-106-76.9-61.3-166-259
Change in inventory-53.8-19.9-44.6-16.2-112-13537.456.4-118-443
Cash from operations70.9138147151122124213413328257
Capital expenditures-68.3-33.8-18.7-42.3-46.1-89.6-61.4-47.5-121-253
Acquisitions-9.92
Purchases of investments-123-153-233-196-244-198-217-436-444-276
Cash from investing-90.6-58.6-98.1-71.2-8.93-136-98.7-170-286-184
Debt issued39060.900
Debt repaid-18.1-11.2-3.25-70.1-12.2-12.2-15.2-12.2
Stock issued5.91.4
Share buybacks-42.4-5.38-20.7-18.8-59.9-47.6-39.5-126-5.23
Cash from financing13.4-54.1-23.2-35.3-42.8-92.9-81-64.9-147-30.7
Exchange rate effect0.52-1.030.70.48-0.18-0.53-0.610.061.39-1.47
Net change in cash-6.1925.326.144.170.5-10433.6179-10542.5
Free cash flow2.6710412910876.134.71523662074.22
Interest paid1.922.222.611.692.442.242.380.3100
Income taxes paid5.221.357.648.477.959.314.216.524.329.4

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $417.39 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin12.0%Gross profit / revenue.
Operating margin10.0%Operating income / revenue.
EBITDA margin11.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin12.0%Pre-tax income / revenue.
Net margin10.2%Net income / revenue.
FCF margin0.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.5%Cash from operations / revenue.
Effective tax rate14.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)21.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)14.0%Net income / average total assets.
Return on invested capital (ROIC)20.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue2.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue5.4%Capital expenditures / revenue.
D&A / revenue1.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y35.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y20.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y19.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y34.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y18.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y20.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y42.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y22.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y25.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y40.6%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y21.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y23.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y42.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y26.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y42.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y24.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y27.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-21.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y16.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-98.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-69.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-43.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y23.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y18.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y17.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y38.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y25.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y19.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.25xCurrent assets / current liabilities.
Quick ratio1.35x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.62x(Cash + short-term investments) / current liabilities.
Liabilities / assets37.2%Total liabilities / total assets.
Interest coverage5,511xOperating income / interest expense.
Working capital$1.76BCurrent assets - current liabilities.
Goodwill and intangibles / assets0.1%(Goodwill + intangible assets) / total assets.
Tangible book value$2.45BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.38xRevenue / average total assets.
Fixed asset turnover9.32xRevenue / average property, plant and equipment.
Inventory turnover5.10xCost of revenue / average inventory.
Days inventory72 days365 x average inventory / cost of revenue.
Receivables turnover5.22xRevenue / average receivables.
Days sales outstanding70 days365 x average receivables / revenue.
Days payables73 days365 x average accounts payable / cost of revenue.
Cash conversion cycle68 daysDays inventory + days sales outstanding - days payables.
FCF conversion0.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow98.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$13.05Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$13.21Net income per basic share, as reported (split-adjusted).
Revenue per share$128.02Revenue / diluted weighted shares.
FCF per share$0.12Free cash flow / diluted weighted shares.
Operating cash flow per share$7.08Cash from operations / diluted weighted shares.
Book value per share$68.49Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$68.42Tangible book value / shares outstanding.
Cash per share$24.42(Cash + short-term investments) / shares outstanding.
Buybacks / FCF123.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$14.95BShare price x shares outstanding.
Enterprise value$14.08BMarket cap + total debt - cash - short-term investments.
P/E31.6xMarket cap / net income. Only when net income is positive.
P/S3.22xMarket cap / revenue.
P/B6.09xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book6.10xMarket cap / tangible book value, when positive.
P/FCF3,542xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF58.3xMarket cap / cash from operations, when positive.
EV/Sales3.03xEnterprise value / revenue.
EV/EBIT30.4xEnterprise value / operating income, when both are positive.
EV/EBITDA26.5xEnterprise value / EBITDA, when both are positive.
EV/FCF3,335xEnterprise value / free cash flow, when both are positive.
FCF yield0.0%Free cash flow / market cap.
Earnings yield3.2%Net income / market cap (the inverse of P/E).
Shareholder yield0.0%(Dividends paid + share buybacks) / market cap.
PEG1.28xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Fabrinet's revenue in fiscal 2026?

Fabrinet reported revenue of $4.64B for fiscal 2026, 35.7% higher than the year before.

Was Fabrinet profitable in fiscal 2026?

Yes. Net income was $473.0M, a net margin of 10.2%.

How much free cash flow did Fabrinet generate in fiscal 2026?

Cash from operations of $256.7M minus capital expenditures of $252.5M left free cash flow of $4.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Fabrinet